Regulation of B lymphocyte and macrophage development by graded expression of PU.1

Science

Volumn 288, Issue 5470, 2000, Pages 1439-1442

  DeKoter, Rodney P ^a   Singh, Harinder ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HEMATOPOIETIC SYSTEM; IMMUNE SYSTEM; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA, COMPLEMENTARY; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; LUMINESCENT PROTEINS; MACROPHAGES; MICE; MUTATION; PROTO-ONCOGENE PROTEINS; RETROVIRIDAE; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC;

MAMMALIA;

EID: 0034717335     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.288.5470.1439     Document Type: Article

References (39)

1. H. Singh, R. P. DeKoter, J. C. Walsh, Cold Spring Harbor Symp. Quant. Biol. 64, 13 (1999).
2. E. W. Scott, M. C. Simon, J. Anastasi, H. Singh, Science 265, 1573 (1994); S. R. McKercher et al., EMBO J. 15, 5647 (1996).
3. E. W. Scott, M. C. Simon, J. Anastasi, H. Singh, Science 265, 1573 (1994); S. R. McKercher et al., EMBO J. 15, 5647 (1996).
4. R. P. DeKoter, J. C. Walsh, H. Singh, EMBO J. 17, 4456 (1998).
5. K. L. Anderson, K. A. Smith, F. Pio, B. E. Torbett, R. A. Maki, Blood 92, 1576 (1998).
6. L. M. Spain, A. Guerriero, S. Kunjibettu, E. W. Scott, J. Immunol. 163, 2681 (1999).
7. E. W. Scott et al., Immunity 6, 437 (1997).
8. R. P. DeKoter and H. Singh, unpublished material.
9. M. C. Olson et al., Immunity 3, 703 (1995).
10. -.
11. -5 M β-mercaptoethanol, 1 U/ml penicillin-streptomycin (complete IMDM), 4 μg/ml polybrene, and 5% conditioned medium from an IL-7- producing cell line [T. H. Winkler, F. Melchers, A. G. Rolink, Blood 85, 2045 (1995)]. Infected cells were removed by gentle pipetting and transferred onto a monolayer of irradiated S17 (11) or OP9 (12) stromal cells. Cultures were fed with fresh IL-7-containing medium every 4 days and analyzed after 10 to 14 days.
12. -5 M β-mercaptoethanol, 1 U/ml penicillin-streptomycin (complete IMDM), 4 μg/ml polybrene, and 5% conditioned medium from an IL-7- producing cell line [T. H. Winkler, F. Melchers, A. G. Rolink, Blood 85, 2045 (1995)]. Infected cells were removed by gentle pipetting and transferred onto a monolayer of irradiated S17 (11) or OP9 (12) stromal cells. Cultures were fed with fresh IL-7-containing medium every 4 days and analyzed after 10 to 14 days.
13. -5 M β-mercaptoethanol, 1 U/ml penicillin-streptomycin (complete IMDM), 4 μg/ml polybrene, and 5% conditioned medium from an IL-7-producing cell line [T. H. Winkler, F. Melchers, A. G. Rolink, Blood 85, 2045 (1995)]. Infected cells were removed by gentle pipetting and transferred onto a monolayer of irradiated S17 (11) or OP9 (12) stromal cells. Cultures were fed with fresh IL-7-containing medium every 4 days and analyzed after 10 to 14 days.
14. L. S. Collins and K. Dorshkind, J. Immunol. 138, 1082 (1987).
15. T. Nakano, H. Kodama, T. Honjo, Science 265, 1098 (1994).
16. / fetal liver progenitors were infected and cultured as described (10). Pro-β cells were selected by passaging for two rounds on S17 with IL-7. Macrophages were generated by transfer of infected progenitors to S17 stroma in the presence of 10 ng/ml M-CSF.
17. 32P-labeled PU.1- or hprt-specific probes. Western blotting was performed using an affinity-purified polyclonal anti-PU.1 antibody (6). A polyclonal anti-TATA binding protein (TBP) antibody (Santa Cruz) was used as a control Western blots were quantified by serial dilution of protein samples.
18. S. C. Feinstein, S. R. Ross, K. R. Yamamoto, J. Mol. Biol. 156, 549 (1982); R. C. Hoeben, A. A. J. Migchielsen, R. C. M. Van Der Jagt, H. Van Ormondt, A. J. Van Der Eb, J. Virol. 65, 904 (1991).
19. S. C. Feinstein, S. R. Ross, K. R. Yamamoto, J. Mol. Biol. 156, 549 (1982); R. C. Hoeben, A. A. J. Migchielsen, R. C. M. Van Der Jagt, H. Van Ormondt, A. J. Van Der Eb, J. Virol. 65, 904 (1991).
20. +/- fetal liver cells on irradiated S17 stromal layers in complete IMDM containing 5% IL-7-conditioned medium.
21. M. J. Klemsz, S. R. McKercher, A. Celada, C. Van Beveren, R. A. Maki, Cell 61, 113 (1990); R. Hromas et al., Blood 82, 2998 (1993); B. Nelsen et al., Science 261, 82 (1993); I. L. Ross et al., Oncogene 9, 121 (1994).
22. M. J. Klemsz, S. R. McKercher, A. Celada, C. Van Beveren, R. A. Maki, Cell 61, 113 (1990); R. Hromas et al., Blood 82, 2998 (1993); B. Nelsen et al., Science 261, 82 (1993); I. L. Ross et al., Oncogene 9, 121 (1994).
23. M. J. Klemsz, S. R. McKercher, A. Celada, C. Van Beveren, R. A. Maki, Cell 61, 113 (1990); R. Hromas et al., Blood 82, 2998 (1993); B. Nelsen et al., Science 261, 82 (1993); I. L. Ross et al., Oncogene 9, 121 (1994).
24. M. J. Klemsz, S. R. McKercher, A. Celada, C. Van Beveren, R. A. Maki, Cell 61, 113 (1990); R. Hromas et al., Blood 82, 2998 (1993); B. Nelsen et al., Science 261, 82 (1993); I. L. Ross et al., Oncogene 9, 121 (1994).
25. M. H. Klemsi and R. A. Maki, Mol. Cell. Biol. 16, 390 (1996).
26. Mutant PU.1 cDNAs were constructed using PCR as described [R. C. Fisher et al., Mol. Cell. Biol. 18, 4347 (1998)] except for the 5′ external primer (5′-CGGCGGCCGCTTACAGGCGTGCAAAATGGAAGGGT-3′) and 3′ external primer (5′-CCGGGCCCTCAGTGGGGCGGGAGGCGCCG-3′) and verified by DNA sequencing. All PU.1 mutant forms contained a 5′ HA-tag sequence. All constructs were blunt-end-ligated into the Hpa I site of MSCV-EGFP. Packaging cell lines were constructed as described (10) and expressed similar concentrations of the various PU.1 derivatives.
27. 4 cells per plate in 2 ml of methylcellulose medium containing 10 ng/ml M-CSF. Colonies were scored using an inverted microscope after 6 days. Colonies were picked, cytospun, and stained with Wright's stain to verify macrophage morphology.
28. A. Cumano, C. J. Paige, N. N. Iscove, G. Brady, Nature 356, 612 (1992); H. Kawamoto, K. Ohmura, Y. Katsura, Int. Immunol. 9, 1011 (1997); G. Lacaud, L. Carlsson, G. Keller, Immunity 9, 827 (1998); L. H. Glimcher and H. Singh, Cell 96, 13 (1999).
29. A. Cumano, C. J. Paige, N. N. Iscove, G. Brady, Nature 356, 612 (1992); H. Kawamoto, K. Ohmura, Y. Katsura, Int. Immunol. 9, 1011 (1997); G. Lacaud, L. Carlsson, G. Keller, Immunity 9, 827 (1998); L. H. Glimcher and H. Singh, Cell 96, 13 (1999).
30. A. Cumano, C. J. Paige, N. N. Iscove, G. Brady, Nature 356, 612 (1992); H. Kawamoto, K. Ohmura, Y. Katsura, Int. Immunol. 9, 1011 (1997); G. Lacaud, L. Carlsson, G. Keller, Immunity 9, 827 (1998); L. H. Glimcher and H. Singh, Cell 96, 13 (1999).
31. A. Cumano, C. J. Paige, N. N. Iscove, G. Brady, Nature 356, 612 (1992); H. Kawamoto, K. Ohmura, Y. Katsura, Int. Immunol. 9, 1011 (1997); G. Lacaud, L. Carlsson, G. Keller, Immunity 9, 827 (1998); L. H. Glimcher and H. Singh, Cell 96, 13 (1999).
32. M. A. Cross et al., Oncogens 9, 3013 (1994); M. T. Voso et al., Proc. Natl. Acad. Sci USA 91, 7932 (1994).
33. M. A. Cross et al., Oncogens 9, 3013 (1994); M. T. Voso et al., Proc. Natl. Acad. Sci USA 91, 7932 (1994).
34. S. Ramkumar, R. P. DeKoter, H. Singh, unpublished material.
35. J. C. Walsh, H.-J. Lee, H. Singh, unpublished material.
36. W. Driever and C. Nusslein-Volhard, Cell 54, 95 (1988).
37. G. Struhl, P. Johnston, P. A. Lawrence, Cell 69, 237 (1992).
38. H. Kulessa, J. Frampton, T. Graf, Genes Dev. 9, 1250 (1995).
39. We thank T. Rolink (Basel) for the IL-7-producing cell line and members of the Singh laboratory for critical reading of the manuscript. This work was supported by the Howard Hughes Medical Institute.